Accepting new patients

Dr. Michael Atkins, MD

Oncology ·  Male · Age 64

Dr. Atkins

Medstar Georgetown University

3800 Reservoir Rd NW Washington, DC 20007

Make an Appointment

Show Phone Number


Dr. Michael Atkins, MD is an oncology specialist in Washington, DC and has been practicing for 32 years. He graduated from Tufts University School Of Medicine in 1980 and specializes in oncology, medical oncology, and more.


Insurance Check

Search for your insurance provider

Dr. Atkins accepts

Accepted insurance can change. Please double-check when making an appointment.

(202) 444-2223

Dr. Atkins accepts the following insurance:

Aetna
Aetna HMO
Choice Plus POS II
Select
Anthem Blue Cross Blue Shield
HealthKeepers HMO
KeyCare PPO
Blue Cross Blue Shield
Cigna
Cigna HMO
Cigna PPO
Great West Healthcare-Cigna PPO
Open Access Plus
Commercial Insurance Company
Coventry Health Care of Delaware
Coventry Health Care of Delaware PPO
Coventry Health Care of Virginia
Coventry Health Care of Virginia HMO
Humana
MultiPlan
PHCS Network PPO
Network Health
UnitedHealthCare
Choice Plus POS
Options PPO

Background Check

Healthgrades does not collect malpractice claims information for District of Columbia
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Atkins' experience treating your condition or procedure

Dr. Atkins' Top Procedures and Conditions

Treatment Frequency
Melanoma
very high
very high

Treatment Frequency

Dr. Atkins treats Melanoma more than 90% of his peers

Dr. Atkins treats this condition more than 90% of his peers

Cancer
normal
normal

Treatment Frequency

Dr. Atkins treats Cancer more than 69% of his peers

Dr. Atkins treats this condition more than 69% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Secondary Malignancies
normal
normal

Treatment Frequency

Dr. Atkins treats Secondary Malignancies more than 68% of his peers

Dr. Atkins treats this condition more than 68% of his peers

Dr. Atkins' conditions and procedures:

  • Anal Disorders
  • Autoimmune Diseases
  • Bleeding Disorders
  • Bone Cancer
  • Brain Disorders
  • Cancer
  • Cancer Treatment
  • Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
  • Chronic Lymphocytic Leukemia
  • Coagulation Disorders (incl. Hemophilia)
  • Esophageal Diseases
  • Eye Cancer
  • Immunotherapy
  • Larynx Conditions
  • Lip Cancer
  • Mediastinal Tumors, Malignant
  • Melanoma
  • Melanoma Removal
  • Melanoma Screening
  • Meningiomas
  • Merkel Cell Carcinoma
  • Minimally Invasive Melanoma Surgery
  • Multiple Myeloma
  • Neuroendocrine Tumors
  • Oral Cancer
  • Osteosarcoma
  • Pancreatic Cancer
  • Secondary Malignancies
  • Skin Cancer
  • Skin Cancer Surgery With Reconstruction
  • Skin Cancer Tumor Treatment
  • Small Intestine Cancer
  • Squamous Cell Carcinoma
  • Stomach and Small Intestine Cancer

About Me

Biography

Michael Atkins, MD is Deputy Director of the Georgetown Lombardi Comprehensive Cancer Center and the School Professor and Vice Chair of the Department of Medical Oncology at Georgetown University Medical Center. He is an internationally recognized e...

Specialties

  • Oncology
  • Cancer Research
  • Medical Oncology

Board Certifications

  • Internal Medicine
  • Medical Oncology

Education

2003
Harvard Medical School
1987
New England Med Center
Fellowship Hospital
1983
New England Med Center
Residency Hospital
1981
New England Med Center
Internship Hospital
1980
Tufts University School Of Medicine
Medical School
1976
Tufts University
Undergraduate School
2003
1987
1983
1981
1980
1976

Awards

Dr. Atkins' Reviews

Likelihood to recommend Dr. Atkins

5.0

Based on 2 reviews

5 Stars
100%
(2)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Atkins?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Atkins' Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Michael Atkins, MD
Reply
Dr. Atkins is an expert in the fight against cancer through immunotherapy. He is caring and dedicated. I have complete confidence in his treatment of my Stage IV Melanoma. I highly recommend him. Stage IV Melanoma, currently No Evidence of Active Disease
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. Michael Atkins, MD?

Leave a review

How was your experience with Dr. Atkins?